Last reviewed · How we verify

NCT02833025

Point-of-care Assessment of Thrombin Generation and Platelet Function in Children Requiring Cardiopulmonary Bypass

Status unknown Last updated 9 May 2018
What this trial tests

trial testing Thrombin generation and Platelet Function Testing in Platelet Function Tests in 130 participants. Status unknown.

Timeline
1 December 2018
Primary endpoint
1 December 2020
1 December 2020

Quick facts

Lead sponsorThe Hospital for Sick Children
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment130
Start date1 December 2018
Primary completion1 December 2020
Estimated completion1 December 2020
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

The Hospital for Sick Children

Who can join

Under 5, any sex, with Platelet Function Tests or Thrombin Generation Tests. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Coagulopathy after cardiopulmonary bypass (CPB) is associated with increased morbidity and mortality. Clot formation and clot stability are important factors in coagulation and hemostasis. As such platelet dysfunction and impaired thrombin generation play a central role in bleeding after cardiac surgery. The primary objective of this study is to evaluate the relationship between point-of-care determined platelet function and thrombin generation and postoperative bleeding in infants and young children undergoing cardiac surgery with cardiopulmonary bypass adjusting for clinically important confounding factors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other The Hospital for Sick Children trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02833025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing